There is 1 paper on non-obese non-alcoholic fatty liver disease in aging research: 1 observational study in people.
1 paper studies it1 more mentions it2 findings
See all 2 papers on non-obese non-alcoholic fatty liver disease
“Multivariate analysis for females demonstrated a significant association of OSO with non-obese NAFLD (odds ratio = 3.737, 95% confidence interval = 1.365-10.233, P = 0.010)”
- Humans1
Associations
2Osteosarcopenic obesity
upin humans1
1 study
Osteosarcopenic obesity
upin humans1
Non-obese non-alcoholic fatty liver disease is associated with osteosarcopenic obesity in humans (multivariate analysis adjusted for plausible confounders) (odds ratio 3.737, 95% CI 1.365-10.233).
“Multivariate analysis for females demonstrated a significant association of OSO with non-obese NAFLD (odds ratio = 3.737, 95% confidence interval = 1.365-10.233, P = 0.010)”
Humansmultivariate analysis adjusted for plausible confoundersfemales
Clinical nutrition ESPEN
Sarcopenic obesity
upin humans1OR 2.367
1 study
Sarcopenic obesity
upin humans1OR 2.367
Sarcopenic obesity is associated with non-obese non-alcoholic fatty liver disease in humans after adjusting for confounders, cross-sectional design (OR 2.367, 95% CI 1.317-4.254, P = 0.004).
“Multivariate analysis demonstrated a significant association between sarcopenic obesity and non-obese NAFLD after adjusting for confounders (odds ratio = 2.367, 95% confidence interval = 1.317-4.254, P = 0.004).”
Humansafter adjusting for confounders, cross-sectional designn = 563
A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity
Clinical nutrition ESPEN